NEUROtransmitter TRANSporters: From single molecules to human pathologies

REGISTRATION NOW OPEN - Brain in Flux - MSCA NeuroTrans Joint Satelitte Meeting 2023

The "Brain in Flux - MSCA NeuroTrans Joint Satellite Meeting 2023" will take place from August 12-15, 2023 in Gaia, Portugal as a satellite meeting to the ISN-ESN biennial meeting. Register now!

All information on the exciting programme, the venue, registration and abstract submission is available at www.meduniwien.ac.at/bif2023. Early bird fees will apply until June 18, 2023.

The programme will feature short talks selected from abstracts. Please register for the meeting and submit your abstract by latest June 18, 2023.

Travel grants will be available for PhD students and early postdoctoral researchers that registered for the conference. All details on the application process on the conference website, application deadline: June 18, 2023.

The organizers hope to welcome many of you there!
_________________________________________________________________________________

NeuroTrans is a European Training Network (ETN) from the Marie Skłodowska-Curie Actions Innovative Training Networks (MSCA ITN) of the European Commission’s Horizon 2020 framework.

An ETN is a structured international PhD training environment. Building on the PhD programmes of the involved Universities, NeuroTrans will establish an international training programme by forming a highly interdisciplinary team of world-leading European researchers from 9 Universities and 5 industry partners.

Training will include most important subdisciplines in quantitative biology, including molecular modelling, computer simulations, biophysics, biochemistry, neurobiology, molecular and structural biology. The vision of NeuroTrans is

• to reach an improved understanding of neurotransmitter: sodium symporter (NSS) function reaching from the molecular level to human pathologies,
• to investigate how psychoactive substances target these transporters,
• to elucidate how disruption of transporter function contributes to neuropsychiatric disease pathobiology.

NeuroTrans makes use of cutting-edge methods to reach this goal, but also develops enabling techniques in biophysics, molecular and structural biology. Especially the industrial partners will establish novel devices for detection in live cells.

Social Media

Find our work on Twitter and on LinkedIn